Addition of Vorinostat to Azacitidine in Higher Risk MDS a Phase II add-on Study in Patients With Azacitidine Failure
Clinical trial NCT01748240 · TERMINATED
Trial details
- NCT number
- NCT01748240
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2013-10-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.